NEUROUROLOGY AND URODYNAMICS, vol.37, no.1, pp.257-262, 2018 (SCI-Expanded)
IntroductionIntravesical glucosaminoglycan (GAG) replacement therapies are commonly used in the treatment of bladder pain syndrome (BPS)/interstitial cystitis (IC). Different intravesical glucosaminoglycan products are currently available. In this prospective study, clinical efficacy of chondroitin sulfate and hyaluronic acid are compared in patients with BPS/IC.